Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             117 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A critical overview of concurrent chemoradiotherapy in cervical cancer Sardi, Juan E.
2004
6 p. 463-470
artikel
2 Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults Picci, Piero
2000
6 p. 502-507
artikel
3 Adjuvant chemotherapy for tumors of one centimeter or less: The law of diminishing returns Soule, Sharon E.
2001
6 p. 529-535
artikel
4 Adjuvant chemotherapy trials: I Patel, Shreyaskumar R.
2000
6 p. 485
artikel
5 Adjuvant chemotherapy trials: II Patel, Shreyaskumar R.
2000
6 p. 486
artikel
6 Angiogenic molecules and mechanisms in breast cancer Wu, Inmin
2000
6 p. 566-571
artikel
7 A "Snapshot" of an ovarian cancer clinical practice: Evidence for viewing the malignancy as a "chronic disease" Markman, Maurie
2005
6 p. 393-394
artikel
8 Biologic directed therapies in gynecologic oncology Farley, John H.
2003
6 p. 459-467
artikel
9 Brain metastases: Biology and the role of the brain microenvironment Puduvalli, Vinay K.
2001
6 p. 467-475
artikel
10 Brain metastases: Still an ‘Orphan’ disease? Gilbert, Mark R.
2001
6 p. 463-466
artikel
11 Brain tumor clinical trials: Pitfalls and promise for the future Gilbert, Mark R.
2000
6 p. 473-475
artikel
12 Brain tumors in children Walter, Andrew W.
2004
6 p. 438-444
artikel
13 Breast cancer prevention trials Rhodes, Deborah J.
2000
6 p. 558-565
artikel
14 Cervical cancer screening Wiley, Dorothy J.
2004
6 p. 497-506
artikel
15 Chemoprevention of FAP with sulindac Meyskens, Frank L.
2002
6 p. 495
artikel
16 Chemotherapy for metastatic tumors to the central nervous system Conrad, Charles A.
2001
6 p. 490-494
artikel
17 Chronic conditions in adult survivors of childhood cancer Wells, Robert J.
2007
6 p. 435-436
artikel
18 Consolidation/maintenance chemotherapy for ovarian cancer Markman, Maurie
2003
6 p. 454-458
artikel
19 Contemporary progress in ovarian cancer screening Walsh, Christine S.
2007
6 p. 485-493
artikel
20 CT screening for lung cancer Bevers, Therese B.
2007
6 p. 501-502
artikel
21 Current and emerging treatment approaches for tobacco dependence Cummings, K. Michael
2006
6 p. 475-483
artikel
22 Current research directions for locally advanced cervix cancer Long, Harry J.
2003
6 p. 468-472
artikel
23 Current treatment and management of retinoblastoma Gombos, Dan S.
2007
6 p. 453-458
artikel
24 Diagnostic dilemmas in cancer medicine: Focusing on the treatable Markman, Maurie
2007
6 p. 429-430
artikel
25 Differentiating agents in pediatric malignancies: All-trans-retinoic acid and arsenic in acute promyelocytic leukemia Calleja, Elizabeth M.
2000
6 p. 519-523
artikel
26 Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma Reynolds, C. Patrick
2000
6 p. 511-518
artikel
27 Discovery of cancer preventive agents from natural products: From plants to prevention Mehta, Rajendra G.
2002
6 p. 478-486
artikel
28 Does tamoxifen improve the outcome of patients who have undergone lumpectomy and radiation for ductal carcinoma in situ? Perez, Edith A.
2000
6 p. 594
artikel
29 Endometrial cancer: The management of high-risk disease Kristensen, Gunnar
2004
6 p. 471-475
artikel
30 Evaluation of the clinical utility of diagnostic versus therapeutic interventions in oncology: Related but quite different processes Markman, Maurie
2006
6 p. 407-408
artikel
31 Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer Moore, Halle C. F.
2000
6 p. 587-593
artikel
32 First-line chemotherapy trial in advanced endometrial carcinoma Fu, Siqing
2004
6 p. 483
artikel
33 Gastrointestinal stromal tumors: Chemotherapy and imatinib Muler, Jeffrey H.
2002
6 p. 499-503
artikel
34 Gastrointestinal stromal tumors: Rationale for surgical adjuvant trials with imatinib Cormier, Janice N.
2002
6 p. 504-509
artikel
35 Gemcitabine plus carboplatin compared with carboplatin alone for platinum-sensitive recurrent ovarian cancer Coleman, Robert L.
2007
6 p. 469-471
artikel
36 Gene therapy for ovarian cancer Kimball, Kristopher J.
2006
6 p. 441-447
artikel
37 Gestational trophoblastic neoplasia: The management of relapsing patients and other recent advances Sarwar, Naveed
2004
6 p. 476-482
artikel
38 Giant cell tumor of bone Yasko, Alan W.
2002
6 p. 520-526
artikel
39 Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer Tewari, Krishnansu S.
2005
6 p. 419-434
artikel
40 Historical progress in the initial management of ovarian cancer: Intraperitoneal chemotherapy Coleman, Robert L.
2006
6 p. 455-464
artikel
41 How to establish a high-risk cancer genetics clinic: Limitations and successes Daly, Mary B.
2005
6 p. 469-474
artikel
42 Imaging of soft-tissue sarcomas Varma, Datla G. K.
2000
6 p. 487-490
artikel
43 Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: Physician and nursing perspectives Anderson, Pete
2006
6 p. 415-422
artikel
44 Induction of apoptosis in lymphoid and myeloid leukemia Schimmer, Aaron D.
2006
6 p. 430-436
artikel
45 Induction therapy for adults with acute lymphoblastic leukemia Wells, Robert J.
2006
6 p. 413-414
artikel
46 Innovative laparoscopic surgery in gynecologic oncology Kehoe, Siobhan M.
2007
6 p. 472-477
artikel
47 Integration of breast imaging into cancer management Esserman, Laura J.
2000
6 p. 572-581
artikel
48 Interferons as antiangiogenic agents Lindner, Daniel J.
2002
6 p. 510-514
artikel
49 Intraperitoneal chemotherapy for frontline ovarian cancer therapy: Vindicated or vilified? Coleman, Robert L.
2006
6 p. 439-440
artikel
50 Intraperitoneal chemotherapy for ovarian cancer Friberg, Gregory
2003
6 p. 447-453
artikel
51 Isolated limb perfusion for extremity sarcoma Feig, Barry W.
2000
6 p. 491-494
artikel
52 Issues and challenges in palliative care for children with cancer Friedman, Debra L.
2004
6 p. 431-437
artikel
53 Juvenile myelomonocytic leukemia Niemeyer, Charlotte Marie
2003
6 p. 510-515
artikel
54 Literature alert 2000
6 p. 478-481
artikel
55 Literature Alert 2001
6 p. 456-459
artikel
56 Literature alert 2003
6 p. 441-443
artikel
57 Literature alert 2004
6 p. 425-427
artikel
58 Literature alert 2002
6 p. 457-459
artikel
59 Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract Frumovitz, Michael
2005
6 p. 435-443
artikel
60 Management of angiosarcoma Budd, G. Thomas
2002
6 p. 515-519
artikel
61 Molecular analysis of pediatric brain tumors Biegel, Jaclyn A.
2004
6 p. 445-452
artikel
62 Molecular characterization of soft tissue tumors Borden, Ernest C.
2002
6 p. 497-498
artikel
63 Molecular genetics of pediatric central nervous system tumors Ullrich, Nicole J.
2006
6 p. 423-429
artikel
64 Molecular screening for breast cancer prevention, early detection, and treatment planning: Combining biomarkers from DNA, RNA, and protein Stemke-Hale, Katherine
2006
6 p. 484-491
artikel
65 Monoclonal antibody-based therapy for neuroblastoma Cheung, Nai-Kong V.
2000
6 p. 547-553
artikel
66 New agents in the treatment of childhood leukemias and myelodysplastic syndromes Corey, Seth J.
2005
6 p. 399-405
artikel
67 New approaches to lung cancer prevention McWilliams, Annette
2002
6 p. 487-494
artikel
68 New markers for cancer detection Wong, Ivy H. N.
2002
6 p. 471-477
artikel
69 New paradigms for therapy for osteosarcoma Nagarajan, Rajaram
2005
6 p. 410-414
artikel
70 Novel immunologic and biologic therapies for breast cancer Gutheil, John C.
2000
6 p. 582-586
artikel
71 On the classification of research DeVita, Vincent T.
2002
6 p. 453-454
artikel
72 Operative management of primary epithelial ovarian cancer Leitao, Mario M.
2007
6 p. 478-484
artikel
73 Pediatric non-Hodgkin’s lymphoma Gross, Thomas G.
2007
6 p. 459-465
artikel
74 Pediatric palliative care Weidner, Norbert J.
2007
6 p. 437-439
artikel
75 Pharmacotherapy for tobacco cessation: Nicotine agonists, antagonists, and partial agonists Karam-Hage, Maher
2007
6 p. 509-516
artikel
76 Phase III clinical trial of maintenance therapy for patients with ovarian cancer Coleman, Robert L.
2005
6 p. 417-418
artikel
77 Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes Sartor, Carolyn I.
2000
6 p. 497-505
artikel
78 Prevention of liver cancer Guyton, Kathryn Z.
2002
6 p. 464-470
artikel
79 Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia Meshinchi, Soheil
2003
6 p. 489-497
artikel
80 Prognostic factors in pediatric Hodgkin disease Schwartz, Cindy L.
2003
6 p. 498-504
artikel
81 Proteomics in cancer screening and management in gynecologic cancer Hu, Wei
2004
6 p. 456-462
artikel
82 Quality of life and gynecologic malignancies Sun, Charlotte C.
2005
6 p. 459-465
artikel
83 Radiotherapy and radiosurgical management of brain metastases Flickinger, John C.
2001
6 p. 484-489
artikel
84 Recent advances in human papillomavirus vaccines Mahdavi, Ali
2006
6 p. 465-472
artikel
85 Recent advances in reconstructive surgery for soft-tissue sarcomas Chang, David W.
2000
6 p. 495-501
artikel
86 Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trial Markman, Maurie
2004
6 p. 421-422
artikel
87 Risk assessment models to estimate cancer probabilities Johnson, Constance M.
2007
6 p. 503-508
artikel
88 Risk-based health monitoring of childhood cancer survivors: A report from the children’s oncology group Nunez, Susan B.
2007
6 p. 440-452
artikel
89 Screening and early detection of skin cancer Linden, Kenneth G.
2004
6 p. 491-496
artikel
90 Screening for cancer: Valuable or not? Meyskens, Frank L.
2004
6 p. 485-490
artikel
91 Screening tests for colorectal cancer: A menu of options remains relevant Allison, James E.
2006
6 p. 492-498
artikel
92 Secondary cytoreduction for patients with recurrent ovarian cancer Díaz-Montes, Teresa P.
2005
6 p. 451-458
artikel
93 Surgery for elderly patients with ovarian cancer Bäuerle, Martin G. A.
2003
6 p. 482-485
artikel
94 Surgical management of brain metastases Weinberg, Jeffrey S.
2001
6 p. 476-483
artikel
95 Surgical staging of cancer: Impact on prognosis and potential for bias in clinical trials Markman, Maurie
2003
6 p. 437-438
artikel
96 Targeting pediatric malignancies for T cell-mediated immune responses Mackall, Crystal L.
2000
6 p. 539-546
artikel
97 Targeting signal transduction Bertino, Joseph R.
2001
6 p. 453-454
artikel
98 The current treatment of recurrent ovarian cancer Herzog, Thomas J.
2006
6 p. 448-454
artikel
99 The development of VAC chemotherapy in Rhabdomyosarcoma: What does one do for an encore? Ruymann, Frederick B.
2003
6 p. 505-509
artikel
100 The merits of vascular targeting for gynecologic malignancies Kamat, Aparna A.
2005
6 p. 444-450
artikel
101 Therapy for acute myeloid leukemia: Intensive timing of induction chemotherapy Wells, Robert J.
2000
6 p. 524-528
artikel
102 Therapy for childhood acute myeloid leukemia: Role of allogeneic bone marrow transplantation Abella, Esteban
2000
6 p. 529-538
artikel
103 The role of adjuvant monoclonal antibody therapy for breast cancer: Rationale and new studies Perez, Edith A.
2001
6 p. 516-522
artikel
104 The role of bisphosphonates as adjuvant therapy for breast cancer Gralow, Julie R.
2001
6 p. 506-515
artikel
105 The role of interval debulking surgery in ovarian cancer Burg, Maria E. L. van der
2003
6 p. 473-481
artikel
106 Treatment considerations in advanced endometrial cancer Kendrick, James E.
2007
6 p. 494-498
artikel
107 Umbilical cord blood transplantation Petropoulos, Demetrios
2005
6 p. 406-409
artikel
108 Web alart 2002
6 p. 455-456
artikel
109 Web alert 2003
6 p. 439-440
artikel
110 Web alert 2004
6 p. 423-424
artikel
111 Web Alert 2001
6 p. 460
artikel
112 Web alert 2007
6 p. 431
artikel
113 Web alert 2000
6 p. 476-477
artikel
114 Web alert 2006
6 p. 409
artikel
115 Web alert 2005
6 p. 395-396
artikel
116 What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer? Velasquez, Jonathan L.
2005
6 p. 475-479
artikel
117 What is the ideal duration of adjuvant therapy for primary breast cancer: Are four cycles of cyclophosphamide and doxorubicin enough? Shulman, Lawrence N.
2001
6 p. 523-528
artikel
                             117 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland